APA (7th ed.) Citation

C, E., L, B., V, B., G, C., M, P., K, T., . . . T, F. (2025). Addressing challenges with Matching-Adjusted Indirect Comparisons to demonstrate the comparative effectiveness of entrectinib in metastatic ROS-1 positive Non-Small Cell Lung Cancer. BMC medical research methodology, 25(1), 57. https://doi.org/10.1186/s12874-025-02500-w

Chicago Style (17th ed.) Citation

C, Esnault, et al. "Addressing Challenges with Matching-Adjusted Indirect Comparisons to Demonstrate the Comparative Effectiveness of Entrectinib in Metastatic ROS-1 Positive Non-Small Cell Lung Cancer." BMC Medical Research Methodology 25, no. 1 (2025): 57. https://doi.org/10.1186/s12874-025-02500-w.

MLA (9th ed.) Citation

C, Esnault, et al. "Addressing Challenges with Matching-Adjusted Indirect Comparisons to Demonstrate the Comparative Effectiveness of Entrectinib in Metastatic ROS-1 Positive Non-Small Cell Lung Cancer." BMC Medical Research Methodology, vol. 25, no. 1, 2025, p. 57, https://doi.org/10.1186/s12874-025-02500-w.